Last reviewed · How we verify

NCT07452081: EMG

Combined Effect of Sensory-motor Integration in Individuals With Postmenopausal Polyneuropathy

Recruiting now NA Last updated 5 March 2026
What this trial tests

NA trial testing sensory motor integration in Sensory-Motor Axonal Neuropathy in 100 participants. Currently enrolling.

Timeline
1 February 2026
Primary endpoint
1 May 2026
1 June 2026

Quick facts

Lead sponsorNew Ismailia National University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment100
Start date1 February 2026
Primary completion1 May 2026
Estimated completion1 June 2026
Sites2 locations across Jordan, Egypt

Drugs / interventions tested

Conditions studied

Sponsor

New Ismailia National University

Who can join

Adults 45 to 55, female only, with Sensory-Motor Axonal Neuropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Detect the combined effect of sensory-motor integration in individuals with postmenopausal polyneuropathy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of sensory motor integration

Trials testing the same drug.

Other New Ismailia National University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07452081.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing